Dilated cardiomyopathy
Conditions
Interventions
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Left ventricular end-diastolic diameter (LVEDd) > 5.0 cm (female), LVEDd > 5.5 cm (male); LVEF < 45%, short axis shortening (LVFS) < 25%; 2. NYHA functional classification II-III; 3. Aged 18-75 years old, male or female, the patient signed the informed consent; 4. Nearly 2 did not take other symptomatic traditional Chinese medicine preparations.
Exclusion criteria
Exclusion criteria: ? Exclusion of viral myocarditis, rheumatic cardiomyopathy, ischemic heart disease, diabetic heart disease, valvular heart disease and other structural heart disease with clear etiology; ? Patients with severe liver and kidney function damage, cancer and mental illness; ? Pregnant and lactating women; ? Patients with severe heart, liver, kidney, blood and nervous system diseases; ? Patients with other causes of uncooperation and poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| End-diastolic diameter;Left ventricular ejection fraction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety indicators;NT-proBNP;Left ventricular fractional shortening;6-Minute Walking Distance;TCM score; | — |
Countries
China
Contacts
Public ContactJun Li
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed